DUBLIN, Jan. 27, 2023 /PRNewswire/ — The “Growth Opportunities and Innovative Use Cases for AI in Clinical Trials” report has been added to ResearchAndMarkets.com’s offering.
As clinical pipelines globally witness a surge in novel complex therapies, the clinical trial industry demands new tools in predictive analytics to improve trial design, planning, and execution. Artificial intelligence is gaining large-scale recognition as support for decentralized trial designs, thus enabling patient-centric clinical trial designs. The rapid adoption of AI/ML algorithms and platforms to structure and utilize electronic health records (EHRs) allows the industry to tap into a vast, rich, and highly relevant data source that holds tremendous potential in improving the global clinical trial landscape.
Incorporating integrated AI-driven solutions in clinical trial design and patient retention will ease the go-to-market strategy for various CROs and pharma players as they will reduce costs, increase efficiency, and support the transition to decentralized trials by means of remote patient recruitment, management, as well as engagement through interactive platforms thus ensuring higher retention. Additionally, these platforms are highly beneficial in the selection of appropriate investigators and trial sites. Randomized control trials (RCTs) are another possible application for sponsors to leverage AI in analyzing vast site-level datasets for greater insight into trial design and implementation.
Leading CROs such as Syneos Health or IQVIA, as well as several pharmaceutical companies such as BMS, have successfully deployed AI-based platforms to support site selection and patient recruitment. Companies (including AstraZeneca and Novartis among others) are also applying AI in clinical trials to enable the optimization of different stages with the intent of reducing the overall trial timelines.
AI technologies bring fundamental innovations for transforming clinical trials, such as collecting and analyzing real-world data, seamlessly combining phases I and II of clinical trials, and developing novel patient-centered endpoints. AI can be leveraged to create standardized, structured, and digital data elements from a range of inputs, and as AI-enabled study design helps optimize and accelerate the creation of patient-centric designs, it significantly reduces patient burden, increases the likelihood of success, decreases the number of amendments, and improves the overall efficiency of trials. Together, big technology providers and pharmaceutical start-ups are setting the course for more effective clinical trials in the future.
Key Issues Addressed
What are the key trends impacting the clinical trial industry in terms of technology implementation?
What are the various application areas for AI in terms of execution of clinical trials?
Who are some of the key industry stakeholders building cutting-edge AI enabled platforms?
What are the industry drivers and barriers impacting the AI enabled clinical trial industry?
What are the key strategies global stakeholders are taking to better serve customers while ensuring growth?
What are the key growth opportunities going forward and call to action for CROs, sponsors and technology participants in the ecosystem?
Key Topics Covered:
1. Strategic Imperatives
2. Growth Opportunity Analysis
Scope of Analysis
Definitions
Segmentation
The Top 3 Clinical Trial Challenges
The AI Value Proposition in Clinical Trials
Why AI Is Critical for Trial Success
The Patient Journey Through AI-enabled Clinical Trials
Growth Drivers
Growth Restraints
Regulatory Scenario-AI Use in Clinical Trials
Vendor Ecosystem
AI in Clinical Trials-Companies-to-Action (C2A) Targets
AI in Clinical Trials-Adoption Timeline and Impact
3. Use Case-Clinical Trial Design
AI Applications in Clinical Trial Design
Vendor Spotlight-Owkin
Industry Use Case and Analyst Perspective
Vendor Spotlight-ConcertAI
Industry Use Case and Analyst Perspective
Other AI Vendors in Clinical Trial Design
4. Use Case-Patient Enrichment, Recruitment, and Enrollment
AI Application in Patient Enrichment, Recruitment, and Enrollment
Vendor Spotlight-Unlearn
Industry Use Case and Analyst Perspective
Vendor Spotlight-TrialWire
Analyst Perspective
Other AI Vendors for Patient Enrichment, Recruitment, and Enrollment
5. Use Case-Patient Monitoring, Medical Adherence, and Retention
AI Application in Patient Monitoring, Adherence, and Retention
Vendor Spotlight-AiCure
Industry Use Case and Analyst Perspective
Vendor Spotlight-AWS
Industry Use Case and Analyst Perspective
Other AI Vendors for Patient Monitoring, Adherence, and Retention
6. Use Case-Investigator and Site Selection
AI Applications in Investigator and Site Selection
Vendor Spotlight-Medidata AcornAI
Industry Use Case and Analyst Perspective
Vendor Spotlight-Deep 6 AI
Industry Use Case and Analyst Perspective
Other AI Vendors for Investigator and Site Selection
7. Other Companies to Watch
8. Growth Opportunity Universe
Growth Opportunity 1-Remote Recruitment to Expand Patient Diversity for Cancer Trials
Growth Opportunity 2-Patient-centric Clinical Trial Design for Better Retention and Monitoring
Growth Opportunity 3-AI-integrated Cloud-based SaaS Delivery Models
List of Exhibits
A selection of companies mentioned in this report includes
AiCure
AWS
ConcertAI
Deep 6 AI
Medidata AcornAI
Owkin
TrialWire
Unlearn
For more information about this report visit https://www.researchandmarkets.com/r/zfj4zr
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/growth-opportunities-and-innovative-use-cases-for-ai-in-clinical-trials-2022-remote-recruitment-to-expand-patient-diversity-for-cancer-trials-301732277.html
SOURCE Research and Markets
ChatGPT maker OpenAI and similar ventures have seen their ideas catch on very quickly, says Elad Gil.
It was cheaper to fuel a gas-powered car for 100 miles than it was to charge a comparable electric vehicle in late 2022, according to Anderson Economic Group.
Glide right into retirement.
In today's video, Jose Najarro, Nick Rossolillo, and Billy Duberstein discuss Taiwan Semiconductor Manufacturing's (NYSE: TSM) earnings and some of the headwinds the company can experience in the upcoming quarters.
About 25% of them have resigned to either working later and retiring at a later date.
Supply and demand will probably come into balance over the next 18 months, says Matt Portillo, an analyst at Tudor Pickering Holt. And, how value investor David Einhorn got his mojo back.
Few cars manage to attain the name recognition of the Fiesta, Ford’s cheap, reliable runabout in which millions of Britons learned to drive.
Economic headwinds sent the S&P 500 into a bear market last year, and the benchmark index is still 16% off its high. Warren Buffett's Berkshire Hathaway treated the drawdown as a buying opportunity, investing $66 billion into the stock market through the first three quarters of 2022. Smart investors like Buffett know that a bear market offers investors a chance to buy good stocks at great prices.
Quiet quitting and remote work may be factors.
If the government prevails in its antitrust case, an asset spinoff is thought to be more likely than a sale.
Cathie Wood, the founder and CEO of Ark Invest, rose to popularity during the coronavirus pandemic thanks to her firm's successful bets on some of the most disruptive tech companies. The tech-heavy Nasdaq Composite Index entered a bear market in 2022, and ended it down 33% for the year. Here are three beaten-down growth stocks that Wood is still bullish on.
Tech giants—as well as McDonald’s, Ford and Pfizer—are some of the companies reporting earnings in the week ahead, as layoffs continue and growth slows.
Vital Farms CEO Russell Diez-Canseco is "scratching his head" over soaring egg prices.
ExxonMobil's quarterly sales, profit likely increased, capping a strong year boosted by high oil and natural gas prices that helped its stock price almost double.
With many Americans living longer and retiring earlier, more and more people have time, health and energy to work in retirement. And this has led to a surge in retirees doing just that. So whether you need the extra cash … Continue reading → The post Four Ways to Make Money in Retirement appeared first on SmartAsset Blog.
The energy sector can put a jolt into your passive income these days. Two energy stocks with big-time yields are Energy Transfer (NYSE: ET) and Pioneer Natural Resources (NYSE: PXD). Energy Transfer recently gave its investors another huge raise.
China's smartphone sales fell 13% year-on-year in 2022, the largest plunge for the sector in a decade as consumers spent cautiously, market research firm IDC said on Sunday. Its total shipments fell 25.1% year-on-year, however. Honor ranked as the second best-selling brand, with shipments growing more than 34%, albeit from a low base.
In this article, we take a look at the top 20 oil exporting countries in 2023. If you want to see more top oil exporting countries in 2023, go directly to Top 5 Oil Exporting Countries in 2023. There are different types of oils. When it comes to energy, oil is often used to mean […]
In this article, we take a look at the top 20 oil importing countries in 2023. If you want to see more top oil importing countries in 2023, go directly to Top 5 Oil Importing Countries in 2023. In this article, oil is defined as crude oil. Because not every country has enough crude oil […]
While many Americans idealize retirement as sitting on the beach and traveling with loved ones, the crushing reality is that many people cannot afford that life in retirement. A recent survey from the TransAmerica Institute gathered data on the top … Continue reading → The post Top 3 Fears Americans Have About Retirement – and How to Combat Them appeared first on SmartAsset Blog.